Pictet & Cie (Europe) Sa Abiomed Inc Transaction History

Pictet & Cie (Europe) Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$224.73 - $338.64 $66,295 - $99,898	-295 Reduced 19.99%	1,181 $292,000
Q1 2022 May 04, 2022	SELL	$277.25 - $366.29 $107,850 - $142,486	-389 Reduced 20.86%	1,476 $489,000
Q4 2021 Feb 02, 2022	BUY	$300.63 - $371.35 $59,224 - $73,155	197 Added 11.81%	1,865 $670,000
Q3 2021 Nov 10, 2021	SELL	$310.19 - $376.2 $48,389 - $58,687	-156 Reduced 8.55%	1,668 $543,000
Q2 2021 Aug 11, 2021	BUY	$262.71 - $351.17 $70,406 - $94,113	268 Added 17.22%	1,824 $569,000
Q1 2021 May 10, 2021	BUY	$285.92 - $355.13 $444,891 - $552,582	1,556 New	1,556 $496,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.